TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy
The new data will help inform treatment decisions for many women with early-stage breast cancer.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | National Institutes of Health (NIH) | Women